MOLECULAR STUDY ON ENDOGENOUS INTERFERON ALPHA 2 IN HCV INFECTED PATIENTS TREATED WITH RECOMBINANT INTERFERON ALPHA
Rasha Shaaban Zaid Mahmoud;
Abstract
Hepatitis C infection affects 170-200 million people worldwide. Egypt has one of the highest prevalence rates in the world. HCV Genotype 4 represents over 90 % of cases in Egypt. The standard therapy for HCV is the pegylated rhIFN-α2 plus Ribavirin. Treat
Other data
| Title | MOLECULAR STUDY ON ENDOGENOUS INTERFERON ALPHA 2 IN HCV INFECTED PATIENTS TREATED WITH RECOMBINANT INTERFERON ALPHA | Other Titles | دراسة جزيئية علي انترفيرون الفا 2 الذاتي في المرضي المصابين بفيروس الكبد الوبائي سي ومعالجين بانترفيرون الفا المدمج | Authors | Rasha Shaaban Zaid Mahmoud | Keywords | MOLECULAR STUDY ON ENDOGENOUS INTERFERON ALPHA 2 IN HCV INFECTED PATIENTS TREATED WITH RECOMBINANT INTERFERON ALPHA | Issue Date | 2009 | Description | Hepatitis C infection affects 170-200 million people worldwide. Egypt has one of the highest prevalence rates in the world. HCV Genotype 4 represents over 90 % of cases in Egypt. The standard therapy for HCV is the pegylated rhIFN-α2 plus Ribavirin. Treat |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 94263r2106.pdf | 319.41 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.